Evaluation of Non-Steriodal Anti-Inflammatory Drug (NSAID) induced Gastrointestinal, Renal and Cardiac complications
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Patients attending the OPD or hospitalized will be screened.
- Registration Number
- CTRI/2014/05/004609
- Lead Sponsor
- Wockhardt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
OPD/indoor adult patients who have been advised or have undergone upper GI endoscopy (for gastrointestinal patients)/ any one or more of the following investigations: ECG, TMT, echocardiography (for cardiac patients)/ any one or more of the following investigations: serum urea, creatinine, creatinine clearance (for renal patients)
Exclusion Criteria
Patients having gastric complications above 4 weeks/cardiac complications above 3 months /renal complications above 6 months will be not be considered eligible
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the prevalence of Gastrointestinal, Renal and Cardiac complications associated with NSAID use in patients.Timepoint: Visit 1
- Secondary Outcome Measures
Name Time Method To study the association between risk factors and Gastrointestinal, Renal and Cardiac complications.Timepoint: Visit 1